Literature DB >> 10349063

Should we offer famciclovir to patients with new-onset herpes zoster?

F Martin1, M F Evans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10349063      PMCID： PMC2328600     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  4 in total

1.  Treatments for postherpetic neuralgia--a systematic review of randomized controlled trials.

Authors:  J Volmink; T Lancaster; S Gray; C Silagy
Journal:  Fam Pract       Date:  1996-02       Impact factor: 2.267

2.  Oral acyclovir for herpes zoster: a double-blind controlled trial in normal subjects.

Authors:  S W Wassilew; S Reimlinger; T Nasemann; D Jones
Journal:  Br J Dermatol       Date:  1987-10       Impact factor: 9.302

3.  A double-blind, placebo-controlled study of oral acyclovir in postherpetic neuralgia.

Authors:  O S Surman; T Flynn; R T Schooley; L Baer; S Parker; M S Hirsch; L G Davis
Journal:  Psychosomatics       Date:  1990       Impact factor: 2.386

4.  Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

Authors:  R J Whitley; H Weiss; J W Gnann; S Tyring; G J Mertz; P G Pappas; C J Schleupner; F Hayden; J Wolf; S J Soong
Journal:  Ann Intern Med       Date:  1996-09-01       Impact factor: 25.391
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.